These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 9201299)

  • 21. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
    Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
    J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo H-2K and H-2D antigen expression in two allogeneic mouse tumours of low immunogenicity.
    Ashley MP; Kotlarski I
    Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():323-8. PubMed ID: 3679289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of a sequestered self peptide by influenza virus-specific CD8+ cytolytic T lymphocytes.
    Fan R; Tykodi SS; Braciale TJ
    J Immunol; 2000 Feb; 164(4):1669-80. PubMed ID: 10657609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.
    Milling SW; Silvers WK; Sai T; Mintz B
    Melanoma Res; 2002 Jun; 12(3):221-30. PubMed ID: 12140378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.
    Low HP; Santos MA; Wizel B; Tarleton RL
    J Immunol; 1998 Feb; 160(4):1817-23. PubMed ID: 9469442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
    Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
    Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes.
    Sibille C; Gould KG; Willard-Gallo K; Thomson S; Rivett AJ; Powis S; Butcher GW; De Baetselier P
    Curr Biol; 1995 Aug; 5(8):923-30. PubMed ID: 7583150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells.
    Kajiwara T; Tanaka T; Kukita K; Kutomi G; Saito K; Okuya K; Takaya A; Kochin V; Kanaseki T; Tsukahara T; Hirohashi Y; Torigoe T; Hirata K; Sato N; Tamura Y
    Eur J Immunol; 2016 Dec; 46(12):2842-2851. PubMed ID: 27667124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
    Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
    Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
    Aosai F; Ohlen C; Ljunggren HG; Höglund P; Franksson L; Ploegh H; Townsend A; Kärre K; Stauss HJ
    Eur J Immunol; 1991 Nov; 21(11):2767-74. PubMed ID: 1936122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competition between MHC class I alleles for cell surface expression alters CTL responses to influenza A virus.
    Tourdot S; Gould KG
    J Immunol; 2002 Nov; 169(10):5615-21. PubMed ID: 12421940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.
    Mann DW; McLaughlin-Taylor E; Wallace RB; Forman J
    J Exp Med; 1988 Jul; 168(1):307-24. PubMed ID: 2456370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor cells expressing a recall antigen are powerful cancer vaccines.
    Schweighoffer T
    Eur J Immunol; 1996 Nov; 26(11):2559-64. PubMed ID: 8921939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
    Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
    J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.